Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma allotted 5,86,666 equity shares to promoter Venkaiah Chowdary Nannapaneni via its rights issue, valued at ~₹44 Crore. This lifts his stake to 14.60%.

Key figures
Value₹44.00 Cr
Source

BSE filing, NSE: NATCOPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Natco Pharma Ltd: key numbers

Share price
₹787.55
Market cap
₹15,449 Cr
Revenue (annual)
₹4,078 Cr
Net profit (annual)
₹1,418 Cr
P/E (TTM)
13.5×Sector 48.7×
Promoter holding
49.39%-0.03% QoQ
FII holding
15.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Natco Pharma Ltd

All →
14:19 IST NSE
Product Launch

Natco Pharma Product Launch

Natco Pharma launches Carboplatin Injection, a Paraplatin® generic, in the U.S. market via its subsidiary. The oncology product addresses a critical U.S. supply shortage.

Other capital structure change announcements

All →